Chen, Wei
Bushinsky, David A.
Article History
First Online: 21 March 2016
Competing interests
: D.A.B. is a consultant for Relyspa, Amgen, Sanofi/Genzyme, and Tricida and has equity interest in Relypsa, Amgen and Tricida. W.C. declares no competing interests.